semaglutide and drinking Can oral reduce alcohol use? Clinical trial shows fewer heavy days Semaglutide Shows Promise In Reducing

Off-label use means that a medication is used for a non-FDA-approved purpose because the prescriber believes it may benefit a patient

The Phase 1 high-dose trial explored doses up to 16 mg, finding that the compound remained well tolerated even at these higher levels

In addition to helping with blood sugars and weight, GLP-1 agonists may also benefit heart health

In addition to the physical symptoms, individuals may also experience a sense of impending doom or anxiety, which can be alarming

for the fasted-morning option, the dose goes in before the first food of the day, with breakfast held until the post-dose window has passed

Mounjaro, a similar diabetes drug produced by Eli Lilly with the active ingredient tirzepatide, launched in mid-2022